Profarma Distribuidora de Produtos Farmacêuticos S.A
Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution of pharmaceutical products in Brazil. It provides pharmaceutical, personal hygiene, and beauty products. The company operates retail stores under the Drogasmil, Farmalife, Drogarias Tamoio and Drogaria Rosário brands. Profarma Distribuidora de Produtos Farmacêuticos S.A. was incorpor… Read more
Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3) - Total Assets
Latest total assets as of September 2025: R$5.64 Billion BRL
Based on the latest financial reports, Profarma Distribuidora de Produtos Farmacêuticos S.A (PFRM3) holds total assets worth R$5.64 Billion BRL as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Profarma Distribuidora de Produtos Farmacêuticos S.A - Total Assets Trend (2003–2024)
This chart illustrates how Profarma Distribuidora de Produtos Farmacêuticos S.A’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Profarma Distribuidora de Produtos Farmacêuticos S.A - Asset Composition Analysis
Current Asset Composition (December 2024)
Profarma Distribuidora de Produtos Farmacêuticos S.A's total assets of R$5.64 Billion consist of 71.6% current assets and 28.4% non-current assets.
| Asset Category | Amount (BRL) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | R$224.22 Million | 4.1% |
| Accounts Receivable | R$1.47 Billion | 26.3% |
| Inventory | R$1.82 Billion | 32.4% |
| Property, Plant & Equipment | R$674.18 Million | 12.0% |
| Intangible Assets | R$189.08 Million | 3.4% |
| Goodwill | R$440.24 Million | 7.8% |
Asset Composition Trend (2003–2024)
This chart illustrates how Profarma Distribuidora de Produtos Farmacêuticos S.A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Profarma Distribuidora de Produtos Farmacêuticos S.A's current assets represent 71.6% of total assets in 2024, an increase from 0.0% in 2003.
- Cash Position: Cash and equivalents constituted 4.1% of total assets in 2024, up from 3.3% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 0.0% in 2003.
- Asset Diversification: The largest asset category is inventory at 32.4% of total assets.
Profarma Distribuidora de Produtos Farmacêuticos S.A Competitors by Total Assets
Key competitors of Profarma Distribuidora de Produtos Farmacêuticos S.A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Profarma Distribuidora de Produtos Farmacêuticos S.A - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Profarma Distribuidora de Produtos Farmacêuticos S.A generates 1.81x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Profarma Distribuidora de Produtos Farmacêuticos S.A generates $ 2.04 in net profit.
Profarma Distribuidora de Produtos Farmacêuticos S.A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.29 | 1.41 | 1.61 |
| Quick Ratio | 0.72 | 0.76 | 1.02 |
| Cash Ratio | 0.08 | 0.09 | 0.00 |
| Working Capital | R$899.70 Million | R$ 1.05 Billion | R$ 940.29 Million |
Profarma Distribuidora de Produtos Farmacêuticos S.A - Advanced Valuation Insights
This section examines the relationship between Profarma Distribuidora de Produtos Farmacêuticos S.A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.75 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 13.7% |
| Total Assets | R$5.62 Billion |
| Market Capitalization | $40.42 Million USD |
Valuation Analysis
Below Book Valuation: The market values Profarma Distribuidora de Produtos Farmacêuticos S.A's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Profarma Distribuidora de Produtos Farmacêuticos S.A's assets grew by 13.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Profarma Distribuidora de Produtos Farmacêuticos S.A (2003–2024)
The table below shows the annual total assets of Profarma Distribuidora de Produtos Farmacêuticos S.A from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | R$5.62 Billion | +13.74% |
| 2023-12-31 | R$4.94 Billion | +13.13% |
| 2022-12-31 | R$4.36 Billion | +8.23% |
| 2021-12-31 | R$4.03 Billion | +7.23% |
| 2020-12-31 | R$3.76 Billion | +18.15% |
| 2019-12-31 | R$3.18 Billion | +10.14% |
| 2018-12-31 | R$2.89 Billion | +10.34% |
| 2017-12-31 | R$2.62 Billion | -3.42% |
| 2016-12-31 | R$2.71 Billion | +18.85% |
| 2015-12-31 | R$2.28 Billion | +24.83% |
| 2014-12-31 | R$1.83 Billion | +2.79% |
| 2013-12-31 | R$1.78 Billion | +24.33% |
| 2012-12-31 | R$1.43 Billion | +16.01% |
| 2011-12-31 | R$1.23 Billion | +15.18% |
| 2010-12-31 | R$1.07 Billion | +5.80% |
| 2009-12-31 | R$1.01 Billion | +9.73% |
| 2008-12-31 | R$922.10 Million | -0.23% |
| 2007-12-31 | R$924.19 Million | +19.01% |
| 2006-12-31 | R$776.56 Million | +80.31% |
| 2005-12-31 | R$430.68 Million | +28.05% |
| 2004-12-31 | R$336.34 Million | +25.45% |
| 2003-12-31 | R$268.11 Million | -- |